Back to Forecasting
SABRActive

Will Constellation Software file a Schedule 13D on Sabre or publicly announce a strategic transaction push before December 31, 2026?

Resolves December 31, 2026(250d)
IG: 0.40

Current Prediction

10%
Likely No
Model Agreement97%
Predictions9 runs
Last UpdatedApril 25, 2026

Why This Question Matters

Tests whether the 15% standstill (through Q1 2027) holds or breaks. A 13D filing or strategic-push announcement would be a meaningful break in the activism settlement — flagged as TAIL_RISK_SEVERITY escalation by black-swan-beacon. NO is the consensus expectation given the standstill. YES would mean either Constellation breached or a friendly transaction is being formed; either way materially shifts GOVERNANCE_ALIGNMENT and forces re-rating.

GOVERNANCE_ALIGNMENTTAIL_RISK_SEVERITY

Prediction Distribution

0%25%50%75%100%
opus
sonnet
haiku
Range: 8%12%Aggregate: 10%
Individual Predictions(9 runs)
opusRun 1
10%

Standstill is contractually binding through Q1 2027 — explicit bar. Year-1 standstill respect rate ~95%. Constellation patient-capital model + Technology Committee placement signals long-term operator. Strategic transaction announcements during active standstill ~3-5%. Net: ~8-12%. Pick 10%.

Standstill binding through Q1 2027Year-1 respect rate 95%Patient-capital modelStrategic transaction during standstill rare
opusRun 2
8%

Constellation has zero precedent for breaking settled-activism standstill. Their model (compound through patient ownership) is incompatible with mid-standstill activism. Friendly take-private signaled in 2026 would be premature given standstill expiration in Q1 2027. Lean low. ~8%.

Zero standstill-break precedentCompound model incompatibilityQ1 2027 expiration is the natural window
opusRun 3
12%

Tail cases for YES: (1) catastrophic Q1 miss + activism settlement clause material adverse change triggers; (2) friendly take-private package announced before Q1 2027 with mutual agreement to dissolve standstill; (3) third-party activist enters above 5% threshold, forcing Constellation defensive disclosure. Sum ~10-15%. Pick 12%.

MAC clause triggerMutual standstill dissolution scenarioThird-party activist scenario
sonnetRun 1
10%

Year-1 standstill respect ~95% + Constellation specific patient-capital model. Strategic transaction announcement during standstill is unusual but not impossible. ~10%.

Year-1 respect rateConstellation modelStandstill commitment
sonnetRun 2
9%

Standstill explicitly bars 13D filing. Strategic transaction announcement requires Sabre Board approval — Board is not under takeover pressure. ~9%.

13D bar explicitSabre Board approval requiredNo takeover pressure
sonnetRun 3
12%

Constellation has potential motive (cost basis $1.16 = 60%+ IRR at $1.82) but standstill economics + reputational protection of long-term-holder brand keep them disciplined. Slight upward bias from strategic-transaction-with-mutual-consent. ~12%.

Motive vs. discipline tensionReputational brandMutual-consent strategic tail
haikuRun 1
10%

Standstill through Q1 2027. Year-1 respect rate 95%. ~10%.

StandstillYear-1 respect
haikuRun 2
9%

Constellation patient capital model + standstill discipline. ~9%.

Patient capitalStandstill
haikuRun 3
11%

Tail scenarios: MAC trigger or mutual strategic transaction announcement. Both low probability. ~11%.

MAC triggerMutual strategic

Resolution Criteria

Resolves YES if (a) Constellation Software (or any of its affiliates including Topicus, Lumine Group, Constellation Software Inc.) files a Schedule 13D with the SEC regarding Sabre Corporation common stock at any point on or before December 31, 2026, OR (b) Sabre or Constellation publicly announces a strategic transaction (sale, merger, take-private, joint venture, or material stake increase above 15%) before December 31, 2026. Resolves NO otherwise.

Resolution Source

SEC EDGAR filings, Sabre press releases, Constellation Software press releases

Source Trigger

Constellation accumulates above 13G threshold or files 13D

insider-investigatorGOVERNANCE_ALIGNMENTHIGH
View SABR Analysis

Full multi-lens equity analysis